SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2020 Financial Results


You May Also Like

TESARO Joins Healthcare Businesswomen’s Association as Corporate Partner

WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA® Phase III Study for Acute Gastroenteritis

 Top-line results are expected in the second quarter of 2017The randomized, double-blind, placebo-controlled Phase III study ...